Repella Robert 4
4 · Vanda Pharmaceuticals Inc. · Filed Oct 25, 2011
Insider Transaction Report
Form 4
Repella Robert
SVP & Chief Commercial Officer
Transactions
- Award
Restricted Stock Units
2011-10-24+60,000→ 60,000 total→ Common Stock (60,000 underlying) - Award
Employee Stock Option (Right to Buy)
2011-10-24+230,000→ 230,000 totalExercise: $5.90Exp: 2021-10-24→ Common Stock (230,000 underlying)
Footnotes (4)
- [F1]The option becomes exercisable with respect to 25% of the shares after 12 months of continuous service with the Issuer, with the balance becoming exercisable in equal monthly installments over the next 36 months of continuous service thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The restricted stock units vest in four equal annual installments beginning January 1, 2013, provided that Mr. Repella has remained in continuous service with the Issuer on each applicable vesting date. The vested shares will be delivered to the Reporting Person upon vesting.
- [F4]Not applicable.